Medical Innovation Exchange

Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%

https://www.fiercebiotech.com/biotech/orameds-oral-insulin-flunks-phase-3-diabetes-test-sending-stock-down-70

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!